[1] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2015更新版).肝脏,2015,20:915-932. [2] Lok AS, McMahon BJ. Chronic hepatitis B: update 2009.Hepatology, 2009, 50: 661-662. [3] Colloredo G,Guido M,Sonzogni A,et al.Impact of liver biopsy size on histological evaluation of chronic viral hepatitis:the smaller the sample,the milder the disease.J Hepatol,2003,39:239-244. [4] Ceylan B,Fincanci M,Yardimci C,et al. Can mean platelet volume determine the severity of liver fibrosis or inflammation in patients with chronic hepatitis B.Eur J Gastroenterol Hepatol,2013, 25: 606-612. [5] 中华医学会肝病学分会,中华医学会感染病学分会.慢性乙型肝炎防治指南(2010年版).肝脏,2011,16:2-16. [6] 朱大年,王庭槐. 生理学. 第8版.北京:人民卫生出版社,2013:68-71. [7] 中华医学会传染病与寄生虫病学分会,中华医学会肝病学分会.病毒性肝炎防治方案.中华传染病杂志,2001,19:56-62. [8] Sakaguchi S,Sakaguchi N,Asano M,et al.Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains(CD25).Breaddown of a single mechanism of self-tolerancecauses various autoimmune diseases.J Immunol,1995,155: 1151-1164. [9] Fu JL,Xu DP,Zhang P,et al.The characterization of regulatory T cells in peripheral blood of HBV-infected patients.Zhonghua Yi Xue Za Zhi,2006,86: 1522-1525. [10] 庄鹏,王湘郴,罗国辉,等.慢性乙型肝炎患者外周血CD4+CD25+ Fox P3+ Treg及HBV抗原特异性CTLs检测的分析.中国病理生理杂志, 2011,27:1786-1789. [11] Franzese O, Kennedy PT, Gehring AJ, et al. Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection. J Virol, 2005, 79: 3322-3328. [12] 邓茜,肖影群,邹正宇,等.慢性乙型肝炎患者抗病毒治疗前后CD4+CD25+ Fox P3+调节性T细胞的变化.广东医学,2012,33:2592-2595. [13] Franzese O,Kenmedy DT,Gehring AJ,et al.Modulation of CD8+ T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection.J Virol,2005, 79: 3322-3328. [14] Sakaguchi S.Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses.Annu Rev Immunol,2004,22:531-562. [15] 莫莉,许礼发.调节性T细胞与风湿性疾病.中华临床医师杂志(电子版),2011,5:3277-3280. [16] 贾瑞萍,赵雪芸.自身免疫性血小板减少性紫癜患者外周血中CD4+CD25+ 调节性T细胞、sFas和sFasL的表达及临床意义.中国实验血液学杂志,2011,19:1264-1267. [17] Fahin NM,Monir E.Functional role of CD4+ CD25+ regulatory T cells and transforming growth factor-betal in childhood immune thrombocytopenic purpura.Egypt J Immunol,2006,13:173-187. [18] Wai CT,Greenson JK,Fontana RJ,et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patient with chronic hepatitis C.Hepatology,2003, 38: 518-526. [19] Forns X,Ampurdanes S,Llovet J M,et al.Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive modle.Hepatology,2002, 36(4 Pt 1): 986-992. [20] Imbert BF,Ratziv V,Pieroni L,et al. Biochemical markers of liver fibrosis in patientas with hepatitis C virus infection: a prosoective study.Lancet,2001,357: 1069-1075. [21] Koda M,Matunaga Y,Kawakami M,et al. FibroIndex: a parctical index for predicting significant fibrosis in patients with chronic hepatitis C.Hepatology,2007,45: 297-306. [22] Lee C M,Leung T K,Wang H J,et al.Evaluation of the effect of partial splentic embolization on platelet values for liver cirrhosis patients with thrombocytopenia.World J Gastroenterol,2007,13: 619-622. [23] Laffi G,Mana F,Gresele P,et al.Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation.Gastroenterology,1992,103: 641-646. |